Stay updated with breaking news from Simpl. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Approximately 5.5% of the shares of the stock are short sold. Based on […]
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 424,400 shares, an increase of 8.9% from the April 15th total of 389,700 shares. Based on an average trading volume of 46,600 shares, the days-to-cover ratio is […]
Impel Pharmaceuticals (NASDAQ:IMPL – Get Rating) is scheduled to release its earnings data before the market opens on Friday, May 12th. Impel Pharmaceuticals Stock Up 12.6 % NASDAQ IMPL opened at $2.60 on Friday. The company has a market capitalization of $61.75 million, a P/E ratio of -0.57 and a beta of -0.26. Impel Pharmaceuticals […]
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) was the recipient of a significant growth in short interest in the month of April. As of April 15th, there was short interest totalling 389,700 shares, a growth of 17.1% from the March 31st total of 332,800 shares. Based on an average daily trading volume, of 42,800 shares, […]
Impel Pharmaceuticals Inc. (NASDAQ:IMPL – Get Rating) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 389,700 shares, a growth of 17.1% from the March 31st total of 332,800 shares. Currently, 5.1% of the company’s shares are sold short. Based on an average […]